Dr. Dilli Babu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2401 W Belvedere Avneue
Medical Education Office
Baltimore, MD 21215Phone+1 410-601-7649Fax+1 410-601-6308
Education & Training
- Tianjin Medical UniversityClass of 2018
Publications & Presentations
PubMed
- Systemic hypertension with VEGFR inhibitor (axitinib) therapy in cancer patients: A meta-analysis and systematic review of randomized controlled trials.Aravind Dilli Babu, Sahib Singh, Anjani Thota, Sanchit Duhan, Chiranjeevi Sainatham
International Journal of Cardiology. Heart & Vasculature. 2024-06-01 - Early assessment of the pharmacokinetic and pharmacodynamic effects following acetylsalicylic acid loading: toward a definition for acute therapeutic response.Paul A Gurbel, Kevin P Bliden, Parshotam Kundan, Danielle Kraft, Rueshil Parekh
Journal of Thrombosis and Thrombolysis. 2024-01-01 - Outcomes of Covid-19 among patients with ischemic heart disease: A propensity matched analysis.Mirza Faris Ali Baig, Aravind Dilli Babu, Bengt Herweg, Debbie A Rinde-Hoffman
Heart & Lung. 2024-08-24
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: